文献速递头颈甲状腺与浅表CT

CT影像组学预测cN0甲状腺乳头状癌中央区淋巴结转移

Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics.
PubMed 文献 · Acad Radiol · 2022-10-08

本研究纳入85例cN0甲状腺乳头状癌患者的97个结节,从平扫、动脉期和静脉期CT提取321个影像组学特征,构建预测中央区淋巴结转移的影像组学标签。该标签在训练集和验证集的AUC分别为0.79和0.77,校准曲线显示预测概率与病理结果一致性良好,决策曲线分析表明模型具有临床实用性。

要点

  • CT影像组学标签有助于术前预测cN0甲状腺乳头状癌的中央区淋巴结转移状态。
  • 训练集AUC 0.79(95%CI 0.67,0.91),验证集AUC 0.77(95%CI 0.55,0.99)。
  • 校准曲线显示预测概率与病理结果一致性良好(训练集p=0.399,验证集p=0.191)。

核心结论

  • CT影像组学标签可帮助预测cN0甲状腺乳头状癌患者的中央区淋巴结转移状态。

研究设计与样本

  • 回顾性研究纳入85例cN0甲状腺乳头状癌患者的97个结节,其中pN0(无中央区淋巴结转移)59个,pN1(有中央区淋巴结转移)38个。
  • 结节分为训练集69个和验证集28个,从平扫、动脉期和静脉期CT图像提取321个影像组学特征。
  • 采用最小冗余最大相关性和最小绝对收缩与选择算子筛选特征并构建影像组学标签,以病理结果为参考标准。

诊断标准与关键数值

  • 影像组学标签区分pN0与pN1的AUC在训练集为0.79(95%CI 0.67,0.91),在验证集为0.77(95%CI 0.55,0.99)。
  • 校准曲线显示影像组学评分预测概率与病理结果一致性良好,训练集p=0.399,验证集p=0.191。
  • 决策曲线分析显示模型具有临床实用性。

临床应用与阅片要点

  • 对于cN0甲状腺乳头状癌患者,可基于平扫、动脉期和静脉期CT提取的影像组学特征辅助评估中央区淋巴结转移风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To explore the feasibility of the preoperative prediction of pathological central lymph node metastasis (CLNM) status in patients with negative clinical lymph node (cN0) papillary thyroid carcinoma (PTC) using a computed tomography (CT) radiomics signature.

MATERIALS AND METHODS: A total of 97 PTC cN0 nodules with CLNM pathology data (pN0, with CLNM, n = 59; pN1, without CLNM, n = 38) in 85 patients were divided into a training set (n = 69) and a validation set (n = 28). For each lesion, 321 radiomic features were extracted from nonenhanced, arterial and venous phase CT images. Minimum redundancy and maximum relevance and the least absolute shrinkage and selection operator were used to find the most important features with which to develop a radiomics signature in the training set. The performance of the radiomics signature was evaluated by receiver operating characteristic curves, calibration curves and decision curve analysis .

RESULTS: Three nonzero the least absolute shrinkage and selection operator coefficient features were selected for radiomics signature construction. The radiomics signature for distinguishing the pN0 and pN1 groups achieved areas under the curve of 0.79 (95% CI 0.67, 0.91) in the training set and 0.77 (95% CI 0.55, 0.99) in the validation set. The calibration curves demonstrated good agreement between the radiomics score-predicted probability and the pathological results in the two sets (p= 0.399, p = 0.191). The decision curve analysis curves showed that the model was clinically useful.

CONCLUSION: This radiomic signature could be helpful to predict CLNM status in cN0 PTC patients.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Peng, Zhang, Wang, et al. Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics. Acad Radiol. 2022. PMID: 36220726. doi:10.1016/j.acra.2022.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。